Interestingly, inhibition of ATM expression in BOEC from COPD patients upregulated SIRT1 levels and reduced senescence (Fig. 5A), suggesting that SIRT1 upregulation through ATM inhibition could be a therapeutic target in these patients. This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.